Naturally Occurring Resistance-Associated Variants to Hepatitis C Virus Direct-Acting Antiviral Agents in Treatment-Naive HCV Genotype 6a-Infected Patients

BACKGROUND AND OBJECTIVE: The direct-acting antiviral agents (DAAs) antiviral therapy has drastically improved the prognosis of hepatitis C virus (HCV) patients. However, the viral drug resistance-associated variants (RAVs) can limit the efficacy of DAAs. For the HCV-6a is not the predominant preval...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhanyi, Liu, Ying, Zhang, Ying, Shao, Xiaoqiong, Luo, Qiumin, Guo, Xiaoyan, Lin, Guoli, Cai, Qingxian, Zhao, Zhixin, Chong, Yutian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661091/
https://www.ncbi.nlm.nih.gov/pubmed/29164151
http://dx.doi.org/10.1155/2017/9849823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661091/
https://www.ncbi.nlm.nih.gov/pubmed/29164151
http://dx.doi.org/10.1155/2017/9849823

Ejemplares similares